课题基金 / 基金详情

Molecular Oncology Training Program

Molecular Oncology Training Program
分子肿瘤学培训计划
批准号:
9316338
负责人:
DAWN HERSHMAN
金额:
$16.02万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-18 至 2021-06-30

项目摘要

项目成果

DAWN HERSHMAN的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):这是一项在哥伦比亚大学建立培训计划的新提案,重点培训医生的研究技术,这将为癌症生物学、诊断和治疗的转化研究奠定职业基础。我们会 识别和招募具有杰出研究潜力、已完成医学肿瘤学临床培训的个人,并为他们作为肿瘤学转化研究人员的富有成效的职业做好准备。我们将利用为期两年的综合计划,包括教学、研讨会、小组会议、课程作业(包括可能的硕士学位)以及哥伦比亚大学教师研究计划内的个性化培训,以发展参与者的职业生涯。资金以分级方式申请,每年最多支持 4 名学员。 分子肿瘤学培训计划的教员由 26 名独立研究人员组成,他们将对学员进行直接监督。教职员工由 NCI、NIH 其他分支机构和其他癌症研究组织统一资助,并已成为广泛的癌症相关学科的思想领袖。参与的教师是根据他们的研究生产力和质量来确定的, 表现出与其他研究人员的合作,通常是跨研究学科的合作,以及支持和发展超越博士后水平的研究职业的历史。学员将根据过去的成就以及他们作为富有成效的独立转化研究人员发展职业的潜力,从一组经过精心挑选的忠诚的医师研究人员中竞争性地选出。 分子肿瘤学培训计划将得到哥伦比亚大学多样化研究资源以及对肿瘤学的持续扩展和承诺的支持,其中包括实验室和临床重点研究。哥伦比亚大学医学中心内占地 300,000 平方英尺的欧文癌症研究中心的开业预示着这一扩张,该中心完全致力于癌症研究,并且血液学和肿瘤内科部门正在不断招募领先的临床转化研究人员。这些变化极大地拓宽了哥伦比亚大学研究的多样性,同时提高了研究质量,使哥伦比亚大学跻身顶级肿瘤学项目之列,并吸引了一批训练有素、致力于转化癌症生物学事业的医生。
英文摘要
 DESCRIPTION (provided by applicant): This is a new proposal to establish a training program at Columbia University focused on training physicians in research techniques that will form the basis of careers in translational investigation of cancer biology, diagnosis and treatment. We will identify and recruit individuals with outstanding research potential who have completed clinical training in medical oncology and prepare them for productive careers as translational investigators in oncology. We will utilize a comprehensive two-year program comprised of didactics, workshops, small group sessions, coursework, including a possible master's degree, and individualized training within the research programs of Columbia University faculty to develop the careers of the participants. Funds are requested in a graded fashion to support up to 4 trainees annually. The Molecular Oncology Training Program faculty is comprised of 26 independent investigators who will provide direct supervision of the trainees. The faculty members are uniformly funded by the NCI, other branches of the NIH and other cancer-focused research organizations and have established themselves as thought-leaders in a broad range of cancer-related disciplines. Participating faculty have been identified on the basis of their research productivity and quality, demonstrated collaboration with other investigators, often across research disciplines, and a history of supporting and developing research careers that transition beyond the post-doctoral level. The trainees will be chosen competitively from a highly select group of committed physician researchers on the basis of past accomplishments and their potential to develop careers as productive, independent translational investigators. The Molecular Oncology Training Program will be supported by the diverse research resources at Columbia University and the ongoing expansion and commitment to oncology that has included both laboratory and clinically focused research. The expansion was heralded by the opening of the Irving Cancer Research Center a 300,000 square-foot building within the Columbia University Medical Center that is entirely dedicated to cancer research and the ongoing recruitment of leading clinical-translational research faculty to the Division of Hematology and Medical Oncology. These changes have significantly broadened the diversity of research at Columbia University with a concomitant increase in quality that has established Columbia in the top tier of oncology programs and has attracted a pool of consummately trained physicians committed to careers in translational cancer biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and Reduce Refill Rates after Cancer Surgery
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
海外基金